France Reports First Human Case of Shamonda Virus

French health and agricultural authorities confirmed the first documented human infection of the Shamonda virus, a pathogen previously known only to affect livestock. The patient, who was severely immunocompromised and undergoing treatment for a serious illness, died in early October at a hospital in Lyon. Officials noted that while the virus has circulated among animals in Africa and Asia for decades, this marks the first instance of human transmission.

The World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) have been notified of the case. In a statement, the WHO indicated that the infection appears to be an isolated event. "Based on current information and knowledge about the transmission of closely related viruses, this is an isolated human case and is unlikely to lead to wider spread at this time," the organization stated.

The primary hypothesis for the infection is a bite from a midge of the Culicoides genus in eastern France. The virus has been circulating among cattle, and to a lesser extent sheep and horses, in that region throughout the spring and summer of 2026. Since its first identification in Europe in late July, the virus has spread across 52 French departments and has been detected in 14 Western European countries, including Germany, Spain, and Portugal.

Initial clinical investigations suggest that the neurological complications observed in the patient prior to death were likely linked to the Shamonda virus. However, French officials emphasized that the death was an exceptional event tied to the patient's precarious state of health. The French Ministry of Health stated that there is no indication of a public health crisis and that no risk to the general population has been identified based on available scientific knowledge.

The Shamonda virus was first identified in Nigeria in the mid-1960s and is primarily transmitted between animals by biting insects. While cattle are considered the main hosts, the virus has also been found in horses, alpacas, sheep, and goats. According to the World Organisation for Animal Health, there are currently no commercially available vaccines to protect against the virus, which has caused significant economic impact in some areas, including a reported 75% drop in milk production on certain affected French dairy farms.

Ongoing clinical, biological, and epidemiological investigations are being conducted under a "One Health" approach, which integrates human, animal, and environmental health expertise. Agencies continue to monitor the situation closely to determine if the virus directly caused or contributed to the patient's death and to assess whether further human infections might occur. For now, authorities maintain that the risk to the public remains minimal.